Evidence map›Paper›PMID 30720580›Full record

ArticlePain2019

The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients.

Jannis E Meents, Elisangela Bressan, Stephanie Sontag, Alec Foerster, Petra Hautvast, Corinna Rösseler, Martin Hampl, Herdit Schüler, Roman Goetzke, Thi Kim Chi Le and 13 more

Registry-linked trialAbstract read
In one paragraph

Article in Pain, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04835779 (Biometric and Biological Data for Diagnosis and Therapy of Pain Patients German), which is not on this map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04835779 unknown statusnot on this mapstarted 2020, after this paper: background citation

Biometric and Biological Data for Diagnosis and Therapy of Pain Patients German: Biometrische Und Biologische Daten für Die Diagnose Und Therapie Bei Schmerzpatienten

TypeobservationalSponsorRWTH Aachen UniversityRan2020 to 2023Enrolled68ConditionsSmall Fiber Neuropathy
3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  7. Article
  8. Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Calcium-sensing receptor regulates Kv7 channels via GBritish journal of pharmacology · 2024
    Article
  14. Article
  15. The pain target NaPflugers Archiv : European journal of physiology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Jannis E MeentsInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Elisangela BressanInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Stephanie SontagDepartment of Cell Biology, Institute for Biomedical Engineering, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Sontag is now with the Taconic Biosciences GmbH, Köln, Germany.
Alec FoersterInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Petra HautvastInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Corinna RösselerInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Martin HamplInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Herdit SchülerInstitute of Human Genetics, Uniklinik RWTH Aachen, Aachen, Germany.
Roman GoetzkeDivision of Stem Cell Biology and Cellular Engineering, Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Thi Kim Chi LeInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Inge Petter KleggetveitSection of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Kim Le CannInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Clara KerthInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Anthony M RushMetrion Biosciences, Cambridge, United Kingdom.
Marc RogersMetrion Biosciences, Cambridge, United Kingdom.
Zacharias KohlDepartment of Molecular Neurology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Martin SchmelzDepartment of Experimental Pain Research Mannheim, Heidelberg University, Mannheim, Germany.
Wolfgang WagnerDepartment of Cell Biology, Institute for Biomedical Engineering, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Sontag is now with the Taconic Biosciences GmbH, Köln, Germany.
Ellen JørumSection of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Barbara NamerInstitute for Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Beate WinnerDepartment of Stem Cell Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Martin ZenkeDepartment of Cell Biology, Institute for Biomedical Engineering, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Sontag is now with the Taconic Biosciences GmbH, Köln, Germany.
Angelika LampertInstitute of Physiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Dr. Bressan is now with the German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chronic pain syndrome inherited erythromelalgia (IEM) is attributed to mutations in the voltage-gated sodium channel (NaV) 1.7. Still, recent studies targeting NaV1.7 in clinical trials have provided conflicting results. Here, we differentiated induced pluripotent stem cells from IEM patients with the NaV1.7/I848T mutation into sensory nociceptors. Action potentials in these IEM nociceptors displayed a decreased firing threshold, an enhanced upstroke, and afterhyperpolarization, all of which may explain the increased pain experienced by patients. Subsequently, we investigated the voltage dependence of the tetrodotoxin-sensitive NaV activation in these human sensory neurons using a specific prepulse voltage protocol. The IEM mutation induced a hyperpolarizing shift of NaV activation, which leads to activation of NaV1.7 at more negative potentials. Our results indicate that NaV1.7 is not active during subthreshold depolarizations, but that its activity defines the action potential threshold and contributes significantly to the action potential upstroke. Thus, our model system with induced pluripotent stem cell-derived sensory neurons provides a new rationale for NaV1.7 function and promises to be valuable as a translational tool to profile and develop more efficacious clinical analgesics.

Indexed as

Action PotentialsElectric StimulationErythromelalgiaGanglia, SpinalHumansInduced Pluripotent Stem CellsMembrane PotentialsNAV1.7 Voltage-Gated Sodium ChannelNociceptorsPainPatch-Clamp TechniquesSensory Receptor CellsTetrodotoxinNAV1.7 Voltage-Gated Sodium ChannelTetrodotoxin

Identifiers

PMID30720580
PMCPMC6554007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.